ReproCELL Incorporated (TYO:4978)
Japan · Delayed Price · Currency is JPY 125.00
+3.00 (2.46%)
Oct 26, 2026, 3:30 PM JST
ReproCELL Market Cap
ReproCELL has a market cap or net worth of 12.98 billion as of October 26, 2026. It is the 26,539th most valuable company in the world and the 2,323rd biggest in Japan. Its market cap has decreased by 23.85% in one year.
Market Cap
12.98B
Enterprise Value
7.36B
Revenue
2.30B
Global Rank
Country Rank
#2,323 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2013, ReproCELL's market cap has decreased from 145.35B to 12.98B, a decrease of -91.07%. That is a compound annual growth rate of -16.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 12.98B | -2.09% |
| Dec 30, 2025 | 13.26B | 35.27% |
| Dec 30, 2024 | 9.80B | -34.19% |
| Dec 29, 2023 | 14.89B | -42.13% |
| Dec 30, 2022 | 25.73B | 35.26% |
| Dec 30, 2021 | 19.02B | -35.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovacell | 21.13B |
| RaQualia Pharma | 16.22B |
| Stella Pharma | 14.67B |
| CanBas | 14.07B |
| AnGes | 11.57B |
| Kubota Pharmaceutical Holdings | 9.57B |
| Immuno-Biological Laboratories | 9.34B |
| StemRIM | 9.28B |